This webinar addressed the impact of drug schedule changes for recombinant herpes zoster vaccine on pharmacy practice.

 

It is estimated that 1 in 3 people will develop shingles in their lifetime. Shingles is a condition that can be sudden and very painful patients. As pharmacists, we are in a key position to help our patients better understand this condition. We covered the risks and long-term impacts of shingles as well as go through some of the basics of shingles. Understanding how it can impact patients and the role vaccination plays in helping protect themselves.

 

We discussed how the new changes in Shingrix schedule can allow better access to this vaccine at pharmacies and your role as the pharmacist in supporting patients in shingles prevention.

 

Finally, we looked at key talking points and programs you can place in your practice to engage patients to protect themselves against shingles.

This webinar is supported by an educational grant from GlaxoSmithKline Inc.